The latest closing stock price for Aptevo Therapeutics as of November 07, 2024 is 0.31.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -70.17% compound annual growth rate over 8 years.
The all-time high Aptevo Therapeutics stock closing price was 4928.00 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 10.80, which is 3383.9% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 0.14, which is 54.8% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 3.04.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -70.17% compound annual growth rate over 8 years.
The all-time high Aptevo Therapeutics stock closing price was 4928.00 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 10.80, which is 3383.9% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 0.14, which is 54.8% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 3.04.